Skip to main content

Highlights

  1. 1
    mBio · 2022
    PMID: 35993728PMCID: PMC9600380DOIFirst author20 citations

Publications

14 publications

Funding

2 grants
Completed grants (2)
  • PI
    The Natural History of Anti-HPA-alloimmunization in a Diverse Patient Population
    Platelet Disorder Support Association, Inc. · 2022–2025
    PDSA 224745-01
  • PI
    The Natural History of Anti-HPA-alloimmunization in a Diverse Patient Population
    Foundation for Women & Girls with Blood Disorders · 2022–2025
    No publications yet
    FWGBD 221681-01

Clinical research

4 studies
Completed & closed trials (4)
  • PI
    A Prospective, Natural History Study to Assess the Occurrence of HPA-1a Alloimmunization in Women Identified at Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
    Rallybio IPA, LLC. · IRB STUDY CLOSURE (as of 2025)
    Fetal and Neonatal Alloimmune Thrombocytopenia
    NCT05345561
  • PI
    The Natural History of Anti-HPA-1a alloimmunization: Pathobiological Correlates
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
  • PI
    The Natural History of Anti-HPA-alloimmunization in a Diverse Patient Population
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
  • PI
    Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Family Assessment Survey - BRANYplus Transfer
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)